Shareholder Action Notice: The Schall Law Firm Encourages Investors in Reata Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/07/22
Shareholder Action Alert: The Schall Law Firm Encourages Investors in Reata Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/06/22
REATA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reata Pharmaceuticals, Inc. - RETAPRNewsWire • 01/05/22
Investor Action Reminder: The Schall Law Firm Encourages Investors in Reata Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 01/05/22
ROSEN, A TOP RANKED FIRM, Encourages Reata Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action - RETAPRNewsWire • 01/05/22
REATA PHARMACEUTICAL, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Reata Pharmaceutical, Inc. in the United States District Court for the Eastern District of TexPRNewsWire • 01/05/22
Bronstein, Gewirtz & Grossman, LLC Reminds Reata Pharmaceuticals, Inc. (RETA) Shareholders of Class Action and Encourages Investors to Contact the FirmBusiness Wire • 01/04/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important February 18 Deadline in Securities Class Action – RETABusiness Wire • 01/02/22
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Reata Pharmaceuticals, Inc. - RETAPRNewsWire • 12/31/21
REATA PHARMACEUTICALS, INC. (NASDAQ: RETA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. (NASDAQ: RETA)PRNewsWire • 12/30/21
RETA LAWSUIT ALERT: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm's Attorneys, Securities Fraud Class Action PendingNewsfile Corp • 12/30/21
Bronstein, Gewirtz & Grossman, LLC Notifies Reata Pharmaceuticals, Inc. (RETA) Shareholders of Class Action and Encourages Investors to Contact the FirmNewsfile Corp • 12/30/21
RETA NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RETAPRNewsWire • 12/29/21
SHAREHOLDER ALERT: Robbins LLP Informs Investors of Class Action Against Reata Pharmaceuticals, Inc. (RETA)Business Wire • 12/29/21
RETA ALERT: Reata Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNewsfile Corp • 12/29/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Reata Pharmaceuticals (RETA) Investors to Filing of Securities Fraud Class Action, Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 12/27/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Reata Pharmaceuticals, Inc. (RETA)Business Wire • 12/27/21
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RETAPRNewsWire • 12/24/21
REATA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals Inc. and Encourages Investors to Contact the FirmBusiness Wire • 12/23/21
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RETABusiness Wire • 12/22/21
REATA PHARMACEUTICALS, INC. (RETA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. (RETA)Newsfile Corp • 12/22/21
DEADLINE: Reata Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RETAPRNewsWire • 12/22/21
Reata Pharmaceuticals, Inc. Company News: Berger Montague Investigates Securities Fraud Allegations Against Reata Pharmaceuticals, Inc. (RETA)Newsfile Corp • 12/22/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 12/21/21
ALERT: Reata Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RETABusiness Wire • 12/21/21
